We are monitoring the impact of COVID-19 & Recession alarm on Europe Nuclear Medicine Market Get in touch with us for detailed analysis Know More

Know More

Share on

Europe Nuclear Medicine Market Research Report - By Diagnostics, Therapeutics, Application & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic And Rest Of Europe) - Industry Analysis, Size, Share, Growth, Trends, Forecast (2022 to 2027)

Published: January, 2022
ID: 106
Pages: 145

Europe Nuclear Medicine Market Size (2022 to 2027)

The European Nuclear Medicine market size is estimated at USD 1.69 billion in 2022 and is expected to reach USD 2.91 billion by 2027, growing at a CAGR of 11.4%.

The rise in the demand to improve diagnostic and treatment procedures is considered to be a significant factor leveling up the need of the market. A growing number of people suffering from chronic and cardiovascular problems is another factor driving the market demand in Europe. The emergence of new applications in radiopharmaceuticals with advanced technology significantly influences the demand of the market. Escalating expenditure on healthcare is additionally propelling the growth of the Nuclear Medicine Market in Europe. The rise in the need for targeted treatment procedures is accelerating the growth rate of the market.

However, stringent rules and regulations by government authorities in approving new products are quietly hindering the demand of the market. The cost of installing and maintaining the equipment in clinical laboratories needs massive amounts where small-scale enterprises cannot afford remains a challenging factor for the market players. Rising complications with the regular usage of the drugs in some patients impede the European Nuclear Medicine Market.

Increasing disposable income in urban areas is straightly expanding the demand for this market. Growing support from the government and non-government organizations through funds on developing nuclear medicine with high quality is setting up growth opportunities for the market in Europe. The rise in awareness over the availability of various treatment procedures among people elevates the growth rate of this market. On-going research on developing new treatment procedures for different diseases at low cost is lavishing the demand of the Nuclear Medicine Market in Europe.

This research report on the European Nuclear Medicine Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Diagnostic Radioisotopes
    • SPECT   
      • Technetium-99m
      • Thallium-201
      • Gallium-67
      • Iodine-23
      • Others
    • PET     
      • Fluorine-18
      • Rubidium-82
      • Others
  • Therapeutic Radioisotopes                
    • Beta Emitters   
      • Iodine-131
      • Yttrium-90
      • Samarium-153
      • Rhenium-186
      • Lutetium-177
    • Alpha Emitters  
      • Radium-223
    • Brachytherapy  
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192

By Application: 

  • Cardiology
  • Lymphoma
  • Thyroid           
  • Neurology        
  • Oncology         
  • Others

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, Europe is growing faster from the past decade and is also to grow at a CAGR of 8.2% during the forecast period. Germany is holding the highest shares of the market, with a rise in capital income. Besides, the adoption of the latest technological developments in the clinical centers is leveraging the growth rate of the market. Following Germany, U.K and France are leading to dominant shares of the market. The rise in awareness over SPECT and PET diagnostic procedures for accurate results is fueling the Nuclear Medicine Market's growth. Increasing concern towards health and people demand effective diagnostic and treatment procedures is prompting the demand for this market. Italy, Spain, Russia, and the Rest of Europe are anticipated to have a significant growth rate in foreseen years with the hospitals and diagnostic centers' growing investments.

Notable companies dominating the European Nuclear Medicine Market are GE Healthcare, Hologic Inc., Medix Inc., Segami Corporation, Positron Corporation, Bracco Imaging S.p.A, Naviscan Inc., Bayer Healthcare, Lantheus Medical Imaging, Inc. and IBA Molecular Imaging.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Analysis Design                                         

                2.3 Research Phases                                      

                                2.3.1 Secondary Research                            

                                2.3.2 Primary Research                 

                                2.3.3 Econometric Modelling                     

                                2.3.4 Expert Validation                  

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type                                        

                                5.1.1 Diagnostic Radioisotopes                 

                                                5.1.1.1 SPECT    

                                                                5.1.1.1.1 Technetium-99m

                                                                5.1.1.1.2 Thallium-201

                                                                5.1.1.1.3 Gallium-67

                                                                5.1.1.1.4 Iodine-23

                                                                5.1.1.1.5 Others

                                                5.1.1.2 PET         

                                                                5.1.1.2.1 Fluorine-18

                                                                5.1.1.2.2 Rubidium-82

                                                                5.1.1.2.3 Others

                                5.1.2 Therapeutic Radioisotopes                              

                                                5.1.2.1 Beta Emitters     

                                                                5.1.2.1.1 Iodine-131

                                                                5.1.2.1.2 Yttrium-90

                                                                5.1.2.1.3 Samarium-153

                                                                5.1.2.1.4 Rhenium-186

                                                                5.1.2.1.5 Lutetium-177

                                                5.1.2.2 Alpha Emitters   

                                                                5.1.2.2.1 Radium-223

                                                5.1.2.3 Brachytherapy   

                                                                5.1.2.3.1 Cesium-131

                                                                5.1.2.3.2 Iodine-125

                                                                5.1.2.3.3 Palladium-103

                                                                5.1.2.3.4 Iridium-192

                5.2 By Application                                           

                                5.2.1 Cardiology                               

                                5.2.2 Lymphoma                             

                                5.2.3 Thyroid                     

                                5.2.4 Neurology               

                                5.2.5 Oncology                 

                                5.2.6 Others                      

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 U.K                                

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8.Market Leaders' Analysis                                                          

                8.1 GE Healthcare                                           

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Hologic Inc.                                

                8.3 Segami Corporation                                

                8.4 Positron Corporation                                              

                8.5 Bracco Imaging S.P.A                                              

                8.6 Naviscan Inc.                                              

                8.7 Bayer Healthcare                                     

                8.8 Lantheus Medical Imaging Inc.                                           

                8.9 IBA Molecular Imaging                                           

                8.10 Medix Inc.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10.Expert Opinions                                                         

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  1. Europe Nuclear Medicine Radiopharmaceuticals Market, By Region, From 2022 - 2027 (USD Million)
  2. Europe Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  3. Europe Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  4. Europe Therapeutic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  5. Europe Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  6. Europe Cardiology Market, By Region, From 2022 - 2027 (USD Million)
  7. Europe Lymphoma Market, By Region, From 2022 - 2027 (USD Million)
  8. Europe Thyroid Market, By Region, From 2022 - 2027 (USD Million)
  9. Europe Neurology Market, By Region, From 2022 - 2027 (USD Million)
  10. Europe Oncology Market, By Region, From 2022 - 2027 (USD Million)
  11. Europe Other Applications Market, By Region, From 2022 - 2027 (USD Million)
  12. Europe Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  13. Europe SPECT Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  14. Europe PET Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  15. Europe Other Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  16. Europe SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  17. Europe Technetium-99m Market, By Region, From 2022 - 2027 (USD Million)
  18. Europe Thallium-201 Market, By Region, From 2022 - 2027 (USD Million)
  19. Europe Gallium-67 Market, By Region, From 2022 - 2027 (USD Million)
  20. Europe Iodine-23 Market, By Region, From 2022 - 2027 (USD Million)
  21. Europe Other SPECT Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  22. Europe PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  23. Europe Fluorine-18 Market, By Region, From 2022 - 2027 (USD Million)
  24. Europe Rubidium-82 Market, By Region, From 2022 - 2027 (USD Million)
  25. Europe Other PET Diagnostic Radioisotopes Market, By Region, From 2022 - 2027 (USD Million)
  26. Europe Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  27. Europe Beta Emitters Market, By Region, From 2022 - 2027 (USD Million)
  28. Europe Alpha Emitters Market, By Region, From 2022 - 2027 (USD Million)
  29. Europe Brachytherapy Market, By Region, From 2022 - 2027 (USD Million)
  30. Europe Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  31. Europe Iodine-131 Market, By Region, From 2022 - 2027 (USD Million)
  32. Europe Yttrium-90 Market, By Region, From 2022 - 2027 (USD Million)
  33. Europe Samarium-153 Market, By Region, From 2022 - 2027 (USD Million)
  34. Europe Rhenium-186 Market, By Region, From 2022 - 2027 (USD Million)
  35. Europe Lutetium-177 Market, By Region, From 2022 - 2027 (USD Million)
  36. Europe Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  37. Europe Radium-223 Market, By Region, From 2022 - 2027 (USD Million)
  38. Europe Other Alpha Emitters Market, By Region, From 2022 - 2027 (USD Million)
  39. Europe Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)
  40. Europe Cesium-131 Market, By Region, From 2022 - 2027 (USD Million)
  41. Europe Iodine-125 Market, By Region, From 2022 - 2027 (USD Million)
  42. Europe Palladium-103 Market, By Region, From 2022 - 2027 (USD Million)
  43. Europe Iridium-192 Market, By Region, From 2022 - 2027 (USD Million)
  44. U.K Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  45. U.K Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  46. Spain Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  47. Spain Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  48. Germany Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  49. Germany Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  50. Italy Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  51. Italy Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  52. France Nuclear Medicine Radiopharmaceuticals Market, By Type, From 2022 - 2027 (USD Million)
  53. France Nuclear Medicine Radiopharmaceuticals Market, By Application, From 2022 - 2027 (USD Million)
  54. U.K Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  55. Spain Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  56. Germany Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  57. Italy Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  58. France Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  59. U.K SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  60. Spain SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  61. Germany SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  62. Italy SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  63. France SPECT Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  64. U.K PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  65. Spain PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  66. Germany PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  67. Italy PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  68. France PET Diagnostic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  69. U.K Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  70. Spain Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  71. Germany Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  72. Italy Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  73. France Therapeutic Radioisotopes Market, By Type, From 2022 - 2027 (USD Million)
  74. U.K Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  75. Spain Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  76. Germany Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  77. Italy Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  78. France Beta Emitters Market, By Type, From 2022 - 2027 (USD Million)
  79. U.K Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  80. Spain Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  81. Germany Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  82. Italy Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  83. France Alpha Emitters Market, By Type, From 2022 - 2027 (USD Million)
  84. U.K Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)
  85. Spain Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)
  86. Germany Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)
  87. Italy Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)
  88. France Brachytherapy Market, By Type, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample